Company: TAK
Filing Date: 2025-01-30
Form Type: 6-K
Source: 0001395064-25-000002
Chunk: 19

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-01-30
Form: 6-K
Chunk 19
---
 |     |           |  494.1 |     |        |  205.8 |

#### Net Cash from Operating Activities
Net Cash from Operating Activities was JPY 835.0 billion ( JPY +397.3 billion ). The increase was mainly due to favorable impacts from Changes in Assets and Liabilities primarily driven by changes in Provisions and Inventories, as well as a higher net profit for the period adjusted for non-cash items and other adjustments.

#### Net Cash used in Investing Activities
Net Cash used in Investing Activities was JPY 347.4 billion ( JPY -55.0 billion ). The decrease was mainly due to a decrease in Acquisition of Intangible Assets, which was partially offset by other investing activities including the investment in U.S. Treasury Marketable Securities (U.S. Treasuries), as well as the upfront payment to AC Immune SA and a minority equity investment in and acquisition of licensing options from Ascentage Pharma Group International.

#### Net Cash from Financing Activiti

#### es
Net Cash used in Financing Activities was JPY 449.6 billion ( JPY +153.4 billion) . The increase was mainly due to the redemption of outstanding commercial papers and of bonds, including hybrid bonds, which was partially offset by an increase in proceeds from issuance of bonds primarily driven by the issuance of hybrid bonds and unsecured U.S. dollar-denominated senior notes.

<div align='center'>11</div>

Takeda Pharmaceutical Company Limited (4502)

Earnings Report ( Kessan Tanshin ) for the Nine-month

Period Ended December 31, 2024 (Consolidated)

(3) Outlook for the Fiscal Year Ending March 31, 2025

The full year consolidated forecast for the fiscal year ending March 31, 2025 (FY2024) has been revised from the previous forecast (announced on October 31, 2024), as follows:

### Consolidated Forecast for the Fiscal Year Ending

#### March 31, 2025
(

#### FY2024
#### )

|                                         |     |     |  Previous Forecast 
 (October 31, 2024) |     |     |   Revised Forecast 
 (January 30, 2025) |     |     | Change vs. Previous Forecast |     |      | Billion JPY or percentage |
|:----------------------------------------|:----|:----|-------------------:|:----|:----|-------------------:|:----|:----|